{"id":"NCT00654381","sponsor":"Boehringer Ingelheim","briefTitle":"Japanese P III vs Voglibose and Placebo","officialTitle":"A Double-blind Phase III Study to Evaluate the Efficacy of BI 1356 5 mg and 10 mg vs. Placebo for 12 Weeks and vs. Voglibose 0.6 mg for 26 Weeks in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control, Followed by an Extension Study to 52 Weeks to Evaluate Long-term Safety","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2010-01","completion":null,"firstPosted":"2008-04-08","resultsPosted":"2011-08-02","lastUpdate":"2014-01-27"},"enrollment":561,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"BI 1356","otherNames":[]},{"type":"DRUG","name":"BI 1356","otherNames":[]},{"type":"DRUG","name":"voglibose placebo","otherNames":[]},{"type":"DRUG","name":"BI 1356 placebo","otherNames":[]},{"type":"DRUG","name":"voglibose","otherNames":[]}],"arms":[{"label":"voglibose 0.2 mg three times a day (TID)","type":"ACTIVE_COMPARATOR"},{"label":"BI 1356 low dose","type":"EXPERIMENTAL"},{"label":"BI 1356 high dose","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of Linagliptin (BI 1356) (5 mg or 10 mg / once daily) compared to placebo given for 12 weeks and voglibose for 26 weeks as mono therapy in patients with type 2 diabetes mellitus with insufficient glycaemic control. Furthermore, long-term safety is evaluated with an extension treatment to 52 weeks.","primaryOutcome":{"measure":"Change From Baseline in HbA1c at Week 12","timeFrame":"12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0.63,"sd":0.08},{"arm":"Linagliptin 5mg","deltaMin":-0.24,"sd":0.06},{"arm":"Linagliptin 10 mg","deltaMin":-0.25,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":47,"countries":["Japan"]},"refs":{"pmids":["22234149","19732457"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":80},"commonTop":["Nasopharyngitis","Back pain","Constipation","Diabetes mellitus","Diarrhoea"]}}